PLA2G2F and psoriasis: Importantly, genetic deletion of sPLA2-IIF in mice protects against epidermal hyperplasia and associated inflammation in models of Th17-dependent psoriasis, Th1-dependent contact hypersensitivity (CHS), and skin carcinogenesis.